{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:09:59Z","timestamp":1778584199312,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Bladder cancer (BC) continues to be a major public health challenge due to its high recurrence and mortality rates, compounded by difficulties in early detection. Identifying novel genetic biomarkers is crucial for improving diagnosis and therapy. This study integrates machine learning with Mendelian randomization (MR) to identify and validate potential biomarkers for BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We analyzed five publicly available Gene Expression Omnibus (GEO) datasets, including both BC and normal tissue samples, to identify differentially expressed genes (DEGs). Data preprocessing included batch effect correction, followed by differential expression and weighted gene co-expression network analysis (WGCNA). We evaluated the diagnostic performance of candidate genes using 113 machine learning models, selecting the best models based on receiver operating characteristic curve analysis. MR analysis was used to assess causal relationships between gene expression and BC risk.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      validation was performed using BC cell lines (SW780, UMUC3, 5637, and T24) and normal uroepithelial cells (SV-HUC-1), with gene expression measured by quantitative real-time PCR and functional assays evaluating cell proliferation and migration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 48 DEGs were identified, with WGCNA revealing the green module as most associated with BC. Machine learning analysis highlighted FAM107A as a key biomarker, achieving high diagnostic accuracy across datasets. The Stepwise Generalized Linear Model (Stepglm)[backward]\u00a0+\u00a0Gradient Boosting Machine (GBM) model performed optimally, achieving the highest area under the curve (AUC). MR analysis confirmed that higher expression of FAM107A is protective against BC risk, with experimental validation showing that FAM107A overexpression inhibits BC cell proliferation and migration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrates the power of combining machine learning and MR to uncover genetic biomarkers for BC. FAM107A emerges as a promising diagnostic and therapeutic target, offering new insights for personalized BC treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003833","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:01:05Z","timestamp":1771441265000},"page":"2969-2987","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Integrating machine learning and Mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies"],"prefix":"10.1097","volume":"112","author":[{"given":"Chaojie","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[{"name":"Shenzhen Institute of Translational Medicine, Shenzhen Second People\u2019s Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China"},{"name":"Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiou","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People\u2019s Hospital, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhui","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People\u2019s Hospital, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changning","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Institute of Translational Medicine, Shenzhen Second People\u2019s Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China"},{"name":"Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"1712\u201321","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet (London, England)"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"key":"R3-20260512","first-page":"1980\u201391","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"R4-20260512","first-page":"244\u201372","article-title":"Bladder cancer in 2010: how far have we come?","volume":"60","author":"Jacobs","year":"2010","journal-title":"Ca A Cancer J Clinicians"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"597\u2013614","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer - current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12951-021-01104-y","article-title":"Application of nanotechnology in the diagnosis and treatment of bladder cancer","volume":"19","author":"Xu","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"533\u201338","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"R8-20260512","first-page":"4911\u201331","article-title":"Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8 + T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study","volume":"110","author":"Li","year":"2024","journal-title":"Int. J. Surg"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"354\u201365","DOI":"10.1016\/j.eururo.2017.03.010","article-title":"Genetic alterations in the molecular subtypes of bladder cancer: illustration in the cancer genome atlas dataset","volume":"72","author":"Choi","year":"2017","journal-title":"Europ Urol"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"1497\u2013507","DOI":"10.1007\/s12094-023-03374-4","article-title":"Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis","volume":"26","author":"Zhao","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"2905\u201314","DOI":"10.1111\/cas.14927","article-title":"Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer","volume":"112","author":"Chen","year":"2021","journal-title":"Cancer Science"},{"key":"R12-20260512","first-page":"203","article-title":"Machine learning in prediction of bladder cancer on clinical laboratory data. diagnostics","volume":"12","author":"Tsai","year":"2022","journal-title":"(Basel, Switzerland)"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"8821\u201332","DOI":"10.1007\/s00330-023-09960-y","article-title":"A machine learning model based on MRI for the preoperative prediction of bladder cancer invasion depth","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"e28208","DOI":"10.1002\/jmv.28208","article-title":"The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two-sample mendelian randomization","volume":"95","author":"Sun","year":"2023","journal-title":"J Med Virol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"2136\u201343","DOI":"10.1002\/ijc.34228","article-title":"The causal association between smoking, alcohol consumption and risk of bladder cancer: a univariable and multivariable Mendelian randomization study","volume":"151","author":"Xiong","year":"2022","journal-title":"Int. J. Cancer"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"103231","DOI":"10.1016\/j.jaut.2024.103231","article-title":"Autoimmune diseases and the risk of bladder cancer: a Mendelian randomization analysis","volume":"146","author":"Li","year":"2024","journal-title":"J Autoimmun"},{"key":"R17-20260512","first-page":"2","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN Guideline","author":"Riaz","year":"2025","journal-title":"Prem J Sci"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12944-023-01988-9","article-title":"Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis","volume":"23","author":"Dai","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"861281","DOI":"10.3389\/fonc.2022.861281","article-title":"Identification of the putative tumor suppressor characteristics of FAM107A via pan-cancer analysis","volume":"12","author":"Ou","year":"2022","journal-title":"Front Oncol"},{"key":"R20-20260512","first-page":"260\u201368","article-title":"FAM107A as a tumor suppressor in bladder cancer inhibits cell proliferation, migration, and invasion","volume":"52","author":"Ou","year":"2022","journal-title":"Ann Clin Lab Sci"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:18:41Z","timestamp":1778581121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003833","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"2025-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}